We are live on ! Find out more
ORIC icon

Oric Pharmaceuticals
ORIC

66 hedge funds and large institutions have $722M invested in Oric Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

71.95% more ownership

Funds ownership: 0% → 71.95% (+72%)

Holders
66
Holders Change
+66
Holders Change %
–
% of All Funds
1.35%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.1%
New
66
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PS
Peter Svennilson
+$152M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$134M
3
O
OrbiMed
New York
+$93.3M
4
EC
EcoR1 Capital
California
+$84.3M
5
IFA
Invus Financial Advisors
New York
+$32.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PS
1
Peter Svennilson
$161M +$152M +4,768,181 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$139M +$134M +4,206,948 New
O
3
OrbiMed
New York
$98.6M +$93.3M +2,921,967 New
EC
4
EcoR1 Capital
California
$89.1M +$84.3M +2,642,218 New
IFA
5
Invus Financial Advisors
New York
$34M +$32.2M +1,007,576 New
BlackRock
6
BlackRock
New York
$29.3M +$27.7M +868,941 New
Wells Fargo
7
Wells Fargo
California
$19.3M +$18.2M +570,961 New
Victory Capital Management
8
Victory Capital Management
Texas
$19.2M +$18.1M +568,120 New
FCMI
9
Foresite Capital Management III
California
$16.8M +$15.9M +496,893 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$14.5M +$13.7M +428,714 New
DM
11
Deerfield Management
New York
$10.1M +$9.58M +300,000 New
ACH
12
ArrowMark Colorado Holdings
Colorado
$8.83M +$8.36M +261,778 New
CC
13
Casdin Capital
New York
$8.48M +$8.03M +251,515 New
MICM
14
Matthews International Capital Management
California
$6.46M +$6.11M +191,568 New
EA
15
Emerald Advisers
Pennsylvania
$6.28M +$5.94M +186,140 New
EMFAT
16
Emerald Mutual Fund Advisers Trust
Pennsylvania
$5.71M +$5.4M +169,168 New
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$5.45M +$5.16M +161,585 New
Jennison Associates
18
Jennison Associates
New York
$5.06M +$4.79M +150,058 New
AG
19
Artal Group
Luxembourg
$5.06M +$4.79M +150,000 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$4.66M +$4.41M +138,126 New
FCMI
21
Foresite Capital Management IV
California
$4.22M +$3.99M +125,000 New
Northern Trust
22
Northern Trust
Illinois
$3.74M +$3.54M +110,852 New
State Street
23
State Street
Massachusetts
$3.31M +$3.13M +97,991 New
Franklin Resources
24
Franklin Resources
California
$3.2M +$3.99M +125,000 New
LCM
25
Laurion Capital Management
New York
$2.6M +$2.46M +77,000 New
1
2 3

ORIC Hedge Fund Activity: Q2 2020 in Review

66 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Oric Pharmaceuticals (ORIC) for Q2 2020, worth a combined $722M.

Buyers outnumbered sellers: 66 funds opened new ORIC positions and 0 closed out — a net gain of 66 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Peter Svennilson, opening a new position worth an estimated $152M.

  • 66 institutional investors held Oric Pharmaceuticals (ORIC) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $722M of Oric Pharmaceuticals stock for Q2 2020.
  • 66 funds opened new Oric Pharmaceuticals positions in Q2 2020 and 0 closed out, a net change of +66 holders.
  • The largest Oric Pharmaceuticals buyer in Q2 2020 was Peter Svennilson, an estimated $152M added.

Based on aggregated 13F filings for Q2 2020.